OrbiMed Launches $600 Million Healthcare-Focused Fund

Sep 1 2011 | 10:48am ET

New York-based investment management firm OrbiMed Advisors has closed a new $600 million healthcare fund.

The Luxembourg-domiciled Royal Opportunities fund will invest worldwide in healthcare royalty streams and provide structured debt capital to healthcare companies. Investors in the fund include endowments, foundations and financial institutions.

OrbiMed has tapped three partners—Samuel D. Isaly, Sven H. Borho and W. Carter Neild—along with a dedicated team of four to oversee the fund.

“Life sciences companies are typically dependent on equity markets to raise new capital,” said Tadd Wessel, a managing director on the Royalty Opportunities team. “With this fund, OrbiMed can offer a minimally dilutive capital alternative to fund product launches, M&A opportunities, new product research, and general corporate purposes.”

OrbiMed, which focuses exclusively on the healthcare sector, has over $5 billion in assets under management. The firm employs over 50 professionals in offices in New York, San Francisco, Shanghai, Mumbai and Israel.


In Depth

Q&A: Decathlon Capital On Revenue-Based Alternative Lending

Oct 30 2017 | 3:49pm ET

The explosion in private credit activity since the end of the financial crisis is...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

CAIS: How Technology is Disrupting the Alternative Investment Industry

Nov 7 2017 | 5:35pm ET

If there’s one thing that alternative investment professionals can agree on, it...